ATE445404T1 - Verwendung von adefovir oder tenofovir zur hemmung von mmtv-artigen viren im zusammenhang mit brustkrebs und primärer biliärer zirrhose - Google Patents
Verwendung von adefovir oder tenofovir zur hemmung von mmtv-artigen viren im zusammenhang mit brustkrebs und primärer biliärer zirrhoseInfo
- Publication number
- ATE445404T1 ATE445404T1 AT05706024T AT05706024T ATE445404T1 AT E445404 T1 ATE445404 T1 AT E445404T1 AT 05706024 T AT05706024 T AT 05706024T AT 05706024 T AT05706024 T AT 05706024T AT E445404 T1 ATE445404 T1 AT E445404T1
- Authority
- AT
- Austria
- Prior art keywords
- adefovir
- tenofovir
- mmtv
- breast cancer
- inhibit
- Prior art date
Links
- WOZSCQDILHKSGG-UHFFFAOYSA-N adefovir depivoxil Chemical compound N1=CN=C2N(CCOCP(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C)C=NC2=C1N WOZSCQDILHKSGG-UHFFFAOYSA-N 0.000 title abstract 3
- 229960004556 tenofovir Drugs 0.000 title abstract 3
- 206010006187 Breast cancer Diseases 0.000 title abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 2
- 229960001997 adefovir Drugs 0.000 title abstract 2
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 title 1
- 208000033222 Biliary cirrhosis primary Diseases 0.000 title 1
- 208000012654 Primary biliary cholangitis Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- SGOIRFVFHAKUTI-ZCFIWIBFSA-N tenofovir (anhydrous) Chemical compound N1=CN=C2N(C[C@@H](C)OCP(O)(O)=O)C=NC2=C1N SGOIRFVFHAKUTI-ZCFIWIBFSA-N 0.000 title 1
- VCMJCVGFSROFHV-WZGZYPNHSA-N tenofovir disoproxil fumarate Chemical compound OC(=O)\C=C\C(O)=O.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N VCMJCVGFSROFHV-WZGZYPNHSA-N 0.000 abstract 2
- MELHEUHXJKQZNC-UHFFFAOYSA-N 2-(6-aminopurin-9-yl)ethoxymethyl-[hydroxy(phosphonooxy)phosphoryl]oxyphosphinic acid Chemical compound NC1=NC=NC2=C1N=CN2CCOCP(O)(=O)OP(O)(=O)OP(O)(O)=O MELHEUHXJKQZNC-UHFFFAOYSA-N 0.000 abstract 1
- 241000713333 Mouse mammary tumor virus Species 0.000 abstract 1
- IACQCQDWSIQSRP-ZCFIWIBFSA-N [(2r)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-[hydroxy(phosphonooxy)phosphoryl]oxyphosphinic acid Chemical compound N1=CN=C2N(C[C@@H](C)OCP(O)(=O)OP(O)(=O)OP(O)(O)=O)C=NC2=C1N IACQCQDWSIQSRP-ZCFIWIBFSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 241001430294 unidentified retrovirus Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53806604P | 2004-01-21 | 2004-01-21 | |
| PCT/US2005/002043 WO2005072748A1 (en) | 2004-01-21 | 2005-01-21 | Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE445404T1 true ATE445404T1 (de) | 2009-10-15 |
Family
ID=34825960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05706024T ATE445404T1 (de) | 2004-01-21 | 2005-01-21 | Verwendung von adefovir oder tenofovir zur hemmung von mmtv-artigen viren im zusammenhang mit brustkrebs und primärer biliärer zirrhose |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20070281911A1 (de) |
| EP (1) | EP1732569B1 (de) |
| JP (1) | JP2007518815A (de) |
| AT (1) | ATE445404T1 (de) |
| AU (1) | AU2005209256B2 (de) |
| CA (1) | CA2553455A1 (de) |
| DE (1) | DE602005017131D1 (de) |
| ES (1) | ES2334149T3 (de) |
| NZ (1) | NZ548532A (de) |
| WO (1) | WO2005072748A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006239677A1 (en) * | 2005-04-25 | 2006-11-02 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Use of compounds to enhance processivity of telomerase |
| RU2301088C2 (ru) * | 2005-09-01 | 2007-06-20 | Ростовский научно-исследовательский онкологический институт МЗ РФ | Способ лечения рецидива рака молочной железы |
| PL2020996T3 (pl) | 2006-05-16 | 2012-04-30 | Gilead Sciences Inc | Sposób i kompozycje do leczenia chorób nowotworowych układu krwiotwórczego |
| ES2681839T3 (es) * | 2009-10-05 | 2018-09-17 | Ambergen Inc. | Un procedimiento para diagnosticar cirrosis biliar primaria (CBP) usando nuevos autoantígenos |
| US20140031250A1 (en) | 2010-10-07 | 2014-01-30 | David Tsai Ting | Biomarkers of Cancer |
| EP3750544B1 (de) | 2011-11-30 | 2025-03-05 | Emory University | Jak-hemmer zur vorbeugung oder behandlung einer durch eine coronaviridae verursachte viralen krankheit |
| EP3760208B1 (de) | 2014-06-25 | 2024-05-29 | The General Hospital Corporation | Targeting von humanem satellit ii (hsatii) |
| EP3939985B1 (de) | 2014-12-26 | 2024-05-08 | Emory University | Pharmazeutische zusammensetzungen umfassend n4-hydroxycytidin derivate zur behandlung oder vorbeugung von influenza- oder coronavirusinfektionen |
| GB201509431D0 (en) * | 2015-06-01 | 2015-07-15 | Equigerminal Sa | Antiviral composition |
| SG11202004403QA (en) | 2017-12-07 | 2020-06-29 | Univ Emory | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
| KR102196711B1 (ko) * | 2018-08-30 | 2020-12-30 | 가톨릭대학교 산학협력단 | 테노포비르 디소프록실 푸마르산을 유효성분으로 함유하는, 간섬유증 예방 또는 치료용 약학적 조성물 |
| US20220143050A1 (en) * | 2019-02-22 | 2022-05-12 | Kazumoto Murata | mTOR Inhibitor |
| US12029783B2 (en) | 2019-07-02 | 2024-07-09 | Virago Vax Inc. | Mammary tumor virus vaccine |
| US12016844B2 (en) | 2019-07-02 | 2024-06-25 | Virago Vax Inc. | Mammary tumor virus suppression |
| EP3993873A4 (de) * | 2019-07-02 | 2023-09-20 | Virago Vax Inc. | Unterdrückung von brusttumoren |
| KR20250004956A (ko) | 2022-03-15 | 2025-01-08 | 롬 테라퓨틱스, 인크. | 질환을 치료하기 위한 화합물 및 방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1220948B1 (de) * | 1999-06-01 | 2008-05-14 | Alton Ochsner Medical Foundation | Identifizierung eines neuartigen retrovirus welcher mit primärer leberzirrhose sowie autoimmunerkrankungen einhergeht |
| DE60039295D1 (de) * | 1999-06-30 | 2008-08-07 | Univ Tulane | Humanes endogenes retrovirus |
| CN1291994C (zh) * | 2000-07-21 | 2006-12-27 | 吉里德科学公司 | 核苷酸膦酸酯类似物前药及其筛选和制备方法 |
| US7214668B2 (en) * | 2002-05-13 | 2007-05-08 | Metabasis Therapeutics, Inc. | Phosphonic acid based prodrugs of PMEA and its analogues |
-
2005
- 2005-01-21 AT AT05706024T patent/ATE445404T1/de not_active IP Right Cessation
- 2005-01-21 EP EP05706024A patent/EP1732569B1/de not_active Expired - Lifetime
- 2005-01-21 CA CA002553455A patent/CA2553455A1/en not_active Abandoned
- 2005-01-21 WO PCT/US2005/002043 patent/WO2005072748A1/en not_active Ceased
- 2005-01-21 US US10/586,627 patent/US20070281911A1/en not_active Abandoned
- 2005-01-21 DE DE602005017131T patent/DE602005017131D1/de not_active Expired - Lifetime
- 2005-01-21 NZ NZ548532A patent/NZ548532A/en unknown
- 2005-01-21 ES ES05706024T patent/ES2334149T3/es not_active Expired - Lifetime
- 2005-01-21 US US11/040,929 patent/US20050239753A1/en not_active Abandoned
- 2005-01-21 JP JP2006551327A patent/JP2007518815A/ja active Pending
- 2005-01-21 AU AU2005209256A patent/AU2005209256B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005072748A1 (en) | 2005-08-11 |
| JP2007518815A (ja) | 2007-07-12 |
| AU2005209256B2 (en) | 2010-11-18 |
| NZ548532A (en) | 2009-09-25 |
| AU2005209256A1 (en) | 2005-08-11 |
| DE602005017131D1 (de) | 2009-11-26 |
| EP1732569A1 (de) | 2006-12-20 |
| ES2334149T3 (es) | 2010-03-05 |
| HK1099228A1 (en) | 2007-08-10 |
| US20070281911A1 (en) | 2007-12-06 |
| US20050239753A1 (en) | 2005-10-27 |
| CA2553455A1 (en) | 2005-08-11 |
| EP1732569B1 (de) | 2009-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE445404T1 (de) | Verwendung von adefovir oder tenofovir zur hemmung von mmtv-artigen viren im zusammenhang mit brustkrebs und primärer biliärer zirrhose | |
| PH12020551244A1 (en) | Pd-1/pd-l1 inhibitors | |
| JOP20220024A1 (ar) | مركبات مساعدة لـ gipr | |
| JOP20180040A1 (ar) | مثبطات pd-1/pd-l1 | |
| CL2004002050A1 (es) | Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros. | |
| EA201000777A1 (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
| ITMI20052171A1 (it) | Composti e-amminocarbonil bicicloepten pirimidindiamminici stereoisomericamente arricchiti e loro uso | |
| GT200600046A (es) | Terapia de combinacion | |
| ZA200709481B (en) | Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV | |
| CY1108399T1 (el) | Τετραϋδροπυριδοθειοφαινια | |
| DK1589956T3 (da) | Transdermal granisetron | |
| NO20064547L (no) | Fremgangsmater for behandling av HIV infeksjon | |
| EA202191257A1 (ru) | Противораковая терапия на основе иммуноцитов, связывающих liv1 | |
| CO2022000481A2 (es) | Inhibidores de enzimas | |
| PH12019550069A1 (en) | Nucleoside phosphate compound and preparation method and use thereof | |
| MX389999B (es) | Estabilizadores de mastocitos para el tratamiento de hipercitoquinemia e infeccion viral | |
| CY1109440T1 (el) | Φωσφοϊνδολες ως αναστολεις hiv | |
| BRPI0515319A (pt) | análogos de quinolona | |
| MX2022000811A (es) | Inhibidores de enzimas. | |
| ATE397000T1 (de) | Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs | |
| GT200600106A (es) | Agentes endoparasiticidas | |
| PH12019502290A1 (en) | Therapeutic agent for blood cancer | |
| EA202091694A1 (ru) | Ингибиторы pd-1/pd-l1 | |
| CL2008001819A1 (es) | Compuestos derivados de fenoxi-fluorobenceno sustituido; composicion farmaceutica; y uso en el tratamiento de enfermedades virales tales como vih y sida. | |
| RU2010139486A (ru) | Способ коррекции гиперэстрадиолемии и нормогонадотропного гипогонадизма у мужчин |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |